Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma

Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma
复制标题

RhoGDI 的过度表达是一种新型的远处转移预测因子,可促进肝细胞癌的细胞增殖和迁移

DOI:
10.1016/j.febslet.2013.12.016
复制
发表时间:
2014-01
期刊:
影响因子:
3.5
通讯作者:
Liang Zhao
Liang Zhao
中科院分区:
生物学3区
文献类型:
--
作者:
Weidong Li;Xuejun Jin;Shuzhong Cui;Liang Zhao

文献摘要

参考文献

相似文献

RhoGDI (Rho GDP-dissociation inhibitor α,简称RhoGDIα)被确定为Rho gtpase的调节因子,但其在癌症中的作用仍存在争议。在这项研究中,RhoGDI在肝细胞癌(HCC)细胞系和具有高转移潜力的组织中表达增加。RhoGDI过表达与术后远处转移相关。RhoGDI在HCC细胞中的表达增强了细胞的增殖和迁移。相反,RhoGDI的敲低引起HCC细胞侵袭性表型的抑制。此外,RhoGDI上调Rho而不上调Rac,并增强PI3K/AKT和MAPK通路活性。我们的研究结果表明,RhoGDI过表达是远处转移的预测因子,在HCC的进展中起重要作用。
RhoGDI (Rho GDP-dissociation inhibitor alpha, or RhoGDIα) was identified as a regulator of Rho GTPases, but its role in cancer remains controversial. In this study, increased expression of RhoGDI was detected in hepatocellular carcinoma (HCC) cell lines and tissues with highly metastatic potential. RhoGDI overexpression correlated with postoperative distant metastasis. Enforced expression of RhoGDI in HCC cells significantly enhanced cell proliferation and migration. Conversely, knockdown of RhoGDI caused an inhibition of the aggressive phenotypes of HCC cells. Furthermore, RhoGDI up-regulated Rho, but not Rac, and enhanced PI3K/AKT and MAPK pathway activity. Our findings suggest that RhoGDI overexpression is a predictor of distant metastasis and plays an important role in the progression of HCC.
DOI: 10.1038/nrdp.2016.18
发表时间: 2016-04-14
影响因子: 81.5
作者:
Llovet, Josep M.;Zucman-Rossi, Jessica;Gores, Gregory
通讯作者: Gores, Gregory
DOI: 10.1016/j.cld.2006.05.012
发表时间: 2006-05-01
影响因子: 5.1
作者:
Marrero, Jorge A;Pelletier, Shawn
通讯作者: Pelletier, Shawn
DOI: 10.1016/j.cnc.2022.04.004
发表时间: 2022-08-29
影响因子: 1.5
作者:
Gilles, HoChong;Garbutt, Tonora;Landrum, Jasmine
通讯作者: Landrum, Jasmine
DOI: 10.1016/s0015-6264(78)80335-6
发表时间: 1986
期刊: The New Zealand medical journal
影响因子: --
作者:
D. Woodfield
通讯作者: D. Woodfield
DOI: 10.3892/or.15.5.1265
发表时间: 2006-05
期刊: Oncology reports
影响因子: 4.2
作者:
T. Goto;M. Takano;M. Sakamoto;A. Kondo;J. Hirata;T. Kita;H. Tsuda;Y. Tenjin;Y. Kikuchi
通讯作者: T. Goto;M. Takano;M. Sakamoto;A. Kondo;J. Hirata;T. Kita;H. Tsuda;Y. Tenjin;Y. Kikuchi